Intellia Therapeutics Inc buy Citigroup Inc.
Start price
28.04.26
/
50%
€11.14
Target price
28.04.27
-
Performance (%)
-7.18%
Price
07.08.26
€10.34
Summary
This prediction is currently active. With a performance of -7.18%, the BUY prediction for Intellia Therapeutics Inc by Citigroup_Inc_ is down slightly. This prediction currently runs until 28.04.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 11.663% | 11.663% |
| iShares Core DAX® | 2.573% | 3.502% |
| iShares Nasdaq 100 | 4.858% | 0.654% |
| iShares Nikkei 225® | 5.590% | -0.246% |
| iShares S&P 500 | 3.250% | 2.083% |
Comments by Citigroup_Inc_ for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NTLA) had its "outperform" rating reaffirmed by Citigroup Inc..
Ratings data for NTLA provided by MarketBeat